This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yokota, J. Articles by Terada, M. Search for Related Content PubMed PubMed Citation Articles by Yokota, J. Articles by Terada, M.

Loss of Heterozygosity on the Short Arm of Chromosome 3 in Carcinoma of the Uterine Cervix¹

National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan

Loss of genes at specific chromosomal loci is a common genetic alteration in human tumors and is thought to be critical for unmasking the recessive genetic changes for tumorigenesis. To learn whether such recessive mutations are involved in the development of carcinoma of the uterine cervix, 18 fresh tumors were analyzed by Southern blot hybridization using 34 polymorphic DNA markers covering 19 different chromosomes. We found loss of heterozygosity at the D3S2 locus on chromosome 3p in all nine patients who could be evaluated. Human papillomavirus type 16 and type 18 were present in seven and three of 18 tumors, respectively, while no amplification of 13 oncogenes, including c-myc and H-ras, was detected in these tumors. These results suggest that recessive genetic changes on chromosome 3p are one of the important genetic alterations for the development of carcinoma of the uterine cervix. Since this locus is also lost commonly in lung cancer and in renal cell carcinoma, it is possible that these three different types of adult tumors result from mutations of the same recessive gene on chromosome 3p.

¹ This work was supported in part by a Grant-in-Aid for a Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan, and Grants-in-Aid from the Ministry of Health and Welfare and the Ministry of Education, Science, and Culture of Japan. N. M. is an awardee of a Research Resident Fellowship from the Foundation for Promotion of Cancer Research.

² To whom requests for reprints should be addressed, at Section of Studies on Metastasis, National Cancer Center Research Institute, 1-1, Tsukiji 5-chome, Chuo-ku, Tokyo 104, Japan.

Received 11/29/88. Revised 3/ 2/89. Accepted 3/29/89.

This article has been cited by other articles:

				J. S. Lea, R. Ashfaq, S. Muneer, D. G. Burbee, D. S. Miller, J. D. Minna, and C. Y. Muller Understanding the Mechanisms of FHIT Inactivation in Cervical Cancer for Biomarker Development Reproductive Sciences, July 1, 2004; 11(5): 329 - 337. [Abstract] [PDF]

				A. S. Tsao, E. S. Kim, and W. K. Hong Chemoprevention of Cancer CA Cancer J Clin, May 1, 2004; 54(3): 150 - 180. [Abstract] [Full Text] [PDF]

				T. C. Krivak, J. W. McBroom, J. Seidman, D. Venzon, B. Crothers, P. J. MacKoul, G. S. Rose, J. W. Carlson, and M. J. Birrer Abnormal Fragile Histidine Triad (FHIT) Expression in Advanced Cervical Carcinoma: A Poor Prognostic Factor Cancer Res., June 1, 2001; 61(11): 4382 - 4385. [Abstract] [Full Text] [PDF]

				D. C. Connolly, D. L. Greenspan, R. Wu, X. Ren, R. L. Dunn, K. V. Shah, R. W. Jones, F. X. Bosch, N. Muñoz, and K. R. Cho Loss of Fhit Expression in Invasive Cervical Carcinomas and Intraepithelial Lesions Associated with Invasive Disease Clin. Cancer Res., September 1, 2000; 6(9): 3505 - 3510. [Abstract] [Full Text]

				R. Wu, D. C. Connolly, R. L. Dunn, and K. R. Cho Restored Expression of Fragile Histidine Triad Protein and Tumorigenicity of Cervical Carcinoma Cells J Natl Cancer Inst, February 16, 2000; 92(4): 338 - 344. [Abstract] [Full Text] [PDF]

				M. J. Birrer, D. Hendricks, J. Farley, M. J. Sundborg, T. Bonome, M. J. Walts, and J. Geradts Abnormal Fhit Expression in Malignant and Premalignant Lesions of the Cervix Cancer Res., October 1, 1999; 59(20): 5270 - 5274. [Abstract] [Full Text] [PDF]

				E. Kieff Current Perspectives on the Molecular Pathogenesis of Virus-Induced Cancers in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome J Natl Cancer Inst Monographs, April 1, 1998; 1998(23): 7 - 14. [Abstract] [Full Text]

				S. Solinas-Toldo, M. Durst, and P. Lichter Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality PNAS, April 15, 1997; 94(8): 3854 - 3859. [Abstract] [Full Text] [PDF]

				E Solomon, J Borrow, and A. Goddard Chromosome aberrations and cancer Science, November 22, 1991; 254(5035): 1153 - 1160. [Abstract] [PDF]

				R Sager Tumor suppressor genes: the puzzle and the promise Science, December 15, 1989; 246(4936): 1406 - 1412. [Abstract] [PDF]